Medication info
Gluriad Tablet 500/5mg

Gluriad Tablet 500/5mg

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tabletGlibenclamide›5mg / 1 tablet
Manufacturer / importer
Daewoong Pharmaceuticals
Appearance
Pale yellow film-coated tablet that is oval-shaped with a convex surface, marked with '5' on one side.
Packaging
60 tablets (20 tablets/PTP) × 3, 120 tablets (20 tablets/PTP) × 6
Approval status
Active

MFDS item code 200307867 · Approved 2003.05.14 · Insurance code 641600200

Summary

Main use
Treatment of type 2 diabetes mellitus in adults
Who takes it
Adults
Adult dose
The usual starting dose is one tablet of metformin hydrochloride/glyburide 500/2.5mg once daily. For patients receiving concomitant metformin hydrochloride and glyburide, administer 2 tablets once daily with a meal. Increase the dose by 1 tablet at intervals of 1 - 2 weeks according to the patient's blood glucose level. The maximum dose is 4 tablets per day of metformin hydrochloride/glyburide 500/5mg.

Ingredients

Importer
Daewoong Pharmaceuticals

Efficacy & effects

Treatment of type 2 diabetes mellitus in adults

  • Insulin-independent diabetes
  • insufficient blood sugar control
  • hypoglycemia.
View approved original text

This medication is used for the treatment of insulin-independent type 2 diabetes in adults. It is prescribed as a second-line treatment when blood sugar control is insufficient with diet and exercise, as well as with monotherapy of metformin or sulfonylureas. Additionally, it is used to replace the combination therapy of metformin and sulfonylureas for patients whose blood sugar control is stable. This helps to effectively manage blood sugar and prevent complications associated with diabetes. This drug improves the normalization of blood sugar in diabetes patients.

How to take

Adult dose

The usual starting dose is one tablet of metformin hydrochloride/glyburide 500/2.5mg once daily. For patients receiving concomitant metformin hydrochloride and glyburide, administer 2 tablets once daily with a meal. Increase the dose by 1 tablet at intervals of 1 - 2 weeks according to the patient's blood glucose level. The maximum dose is 4 tablets per day of metformin hydrochloride/glyburide 500/5mg.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia and must be used with great caution. Lactic acidosis is a dangerous condition where lactic acid accumulates excessively in the blood, which can be life-threatening in severe cases. Furthermore, it may increase the risk of cardiovascular diseases, so patients with heart conditions should be especially cautious. It should not be used in patients with moderate or severe renal impairment, heart failure, or those who have recently experienced a myocardial infarction. Before any tests involving iodine contrast agents, this medication should be discontinued and renal function should be assessed before resuming. It is also contraindicated in pregnant or nursing women, and in patients taking certain medications. Patients taking this medication should have regular meals, be well-informed about hypoglycemic symptoms, and take immediate appropriate action if hypoglycemia occurs. Gastrointestinal disturbances may commonly occur; gradually increasing the dosage can help alleviate symptoms. Patients with impaired liver function or those consuming excessive alcohol should be cautious with this medication. Regular monitoring of blood glucose, renal function, liver function, and blood tests is necessary, and if any abnormal symptoms occur, a doctor should be consulted immediately. Overdose may result in hypoglycemia or lactic acidosis, necessitating emergency treatment. Caution should be exercised when driving or operating machinery if blurriness of vision or hypoglycemic symptoms frequently occur. It should be stored out of the reach of children, and it is safe not to transfer it to another container.

Side effects

Lactic acidosis, hypoglycemia, upper abdominal pain, diarrhea, nausea, vomiting, abdominal pain, loss of appetite, unpleasant or metallic taste, pruritus, urticaria, maculopapular rash, allergic vasculitis, erythema multiforme, exfoliative dermatitis, photosensitivity, shock, leukopenia, thrombocytopenia, agranulocytosis, hemolytic anemia, bone marrow aplasia, pancytopenia, decreased serum vitamin B12 levels, increased liver enzymes, hepatitis, hepatic porphyria, cutaneous porphyria, elevated serum urea and creatinine levels, episodic hyponatremia, visual disturbances, upper respiratory tract infections, headache, dizziness, tremors, sweating, hunger, increased urination, severe thirst, dry skin, bloating, xerostomia, increased appetite, urinary difficulty, fatty liver, joint pain, insomnia, cold sensation

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Pale yellow film-coated tablet that is oval-shaped with a convex surface, marked with '5' on one side.

Package unit

60 tablets (20 tablets/PTP) × 3, 120 tablets (20 tablets/PTP) × 6

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.